The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation | Synapse
April 19, 2017Open Access
The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation
Key Points
Key points are not available for this paper at this time.
Abstract
Australian New Zealand Clinical Trials Registry ACTRN12613000607774.